Home > Insider Trading > Filing (0001522767-23-000111)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1522767	Marimed Inc.	MRMD	Medicinal Chemicals & Botanical Products (2833)	274672745

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789645	R Jon Levine	C/O Marimed Inc. 10 Oceana Way Norwood, MA 02062	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-10-27	138,889	$0.00	20,240,472	No	4	M	Direct
Common Stock	Disposition	2023-10-27	41,590	$0.32	20,198,882	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $.001 Per Share	Restricted Stock Units (RSU)	Disposition	2023-10-27	138,889	$0.00	138,889	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
555,555			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,684,640	Indirect	By the Jon Levine Family Trust

Footnotes

RSUs convert to shares of common stock on a one-for-one basis.
Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person prior to February 27, 2023 to satisfy tax withholding obligations in connection with the vesting of RSUs.
These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.